Optimal strategy for management of pituitary disease in the growth hormone-deficient teenager

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue SUPPL. 6, 2000, Pages 1343-1348

  Monson, J P ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Adolescent adult transition; Hypopituitarism; Pituitary disease

Indexed keywords

CORTISONE ACETATE; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; SEX HORMONE;

ADOLESCENT; BODY HEIGHT; BONE MASS; CONFERENCE PAPER; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS DISEASE; PATIENT CARE;

EID: 0034497796     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem-2000-s605     Document Type: Conference Paper

References (32)

1. Replacement dose, metabolism and bioavailability of levothyroxine in the treatment of hypothyroidism
2. Corticosteroid replacement therapy: Twice or thrice daily?
3. The assessment of glucocorticoid replacement therapy
4. Baseline characteristics and diagnosis of GHD in 665 adults with hypopituitarism
5. Beneficial effects of growth hormone treatment in GH-deficient adults
6. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency
7. The effect of growth hormone administration in growth hormone-deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition
8. Treatment of adults with growth hormone deficiency with recombinant human growth hormone
9. The effect of low-dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults
10. GH replacement in 1034 growth hormone deficient hypopituitary adults: Demographic and clinical characteristics, dosing and safety
11. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
12. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass
13. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone-deficient young adults
14. Discontinuation of growth hormone therapy in growth hormone deficiency patients: Assessment of body fat mass using bioelectrical impedance
15. Discontinuation of growth hormone (GH) treatment: Metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects
16. Body composition, bone metabolism and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses
17. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: A two-year placebo-controlled study
18. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults
19. Increased arterial intima-media thickness in childhood onset growth hormone deficiency
20. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults
21. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment
22. The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood
23. Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth
24. Growth hormone retesting and auxological data in 131 GH-deficient patients after completion of treatment
25. How should we transfer patients from paediatric to adult clinics?
26. Diagnosis of growth hormone deficiency in adults
27. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3
28. Optimising growth hormone replacement by dose titration in hypopituitary adults
29. When and how to transfer patients from paediatric to adult endocrinologists: Experience from St Bartholomew's Hospital, London
30. Adult growth hormone deficiency
31. What happens when growth hormone is discontinued at completion of growth? Metabolic aspects
32. Evidence-based approach to growth hormone replacement therapy in adults, with special emphasis on body composition